VFA
GHDX

Virtus Fund Advisers’s Genomic Health, Inc. GHDX Stock Holding History

Virtus Fund Advisers’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,424
Closed -$39K – 2263
2014
Q2 		$39K Buy
+1,424
New +$37.9K ﹤0.01% 2037

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtus Fund Advisers's GHDX Position: Q3 2014 in Review

Virtus Fund Advisers sold out of Genomic Health, Inc. (GHDX) in Q3 2014, closing a stake of 1,424 shares — an estimated $39K sold.

Virtus Fund Advisers first reported a position in GHDX in Q2 2014 and held it in 1 quarter. The position peaked at $39K in Q2 2014. 107 funds tracked by Wall St. Rank hold GHDX as of Q3 2014.

  • Virtus Fund Advisers reported no remaining Genomic Health, Inc. position as of Q3 2014 after selling out during the quarter.
  • Virtus Fund Advisers sold 1,424 Genomic Health, Inc. shares in Q3 2014, an estimated $39K.
  • Virtus Fund Advisers first reported a position in Genomic Health, Inc. in Q2 2014 and held it in 1 quarter.
  • Virtus Fund Advisers's Genomic Health, Inc. position peaked at $39K in Q2 2014.
  • 107 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2014.

Based on Virtus Fund Advisers's 13F filing for Q3 2014, filed 31 Oct 2014.